Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Quickcomparison

Dose Range Vesilute 20–40 mg Prostamax 5–10 mg Frequency Once daily Administration Oral (capsule/tablet) Sublingual (enteric-coated capsules) Cycle Length 12+ weeks Onset Speed Gradual (3-4 weeks) Evidence Level Moderate human trials (Phase 1-2) Limited human

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Dose Range
  • Vesilute
  • 20–40 mg
  • Prostamax
  • 5–10 mg
  • Frequency
  • Once daily
  • Administration
  • Oral (capsule/tablet)
  • Sublingual (enteric-coated capsules)
  • Cycle Length
  • 12+ weeks
  • Onset Speed
  • Gradual (3-4 weeks)
  • Evidence Level
  • Moderate human trials (Phase 1-2)
  • Limited human trials
  • Efficacy

Related resources

More comparisons

comparison

Quickcomparison

Dose Range Testagen 5–10 mg Prostamax Frequency Once daily Administration Sublingual (enteric-coated capsules) Cycle Length 12+ weeks Onset Speed Gradual (3-4 weeks) Evidence Level Limited …

Source: peptideinitiative.comOpen reference →